ScreenerHero

BIO Biofarm S.A.

BVB · RO · Healthcare · Drug Manufacturers - Specialty & Generic · biofarm.ro
1.370RON0.00%Mkt Cap: 294.94M $P/E: 19.57

Biofarm S.A. manufactures pharmaceutical products. The company's products include cardiovascular, digestive and metabolic, genito-urinary, ophthalmological, endocrine, nervous system, osteo-muscular, respiratory and ENT,…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap294.94M USD
Enterprise Value249.74M USD
Revenue (TTM)64.29M USD
Gross Profit59.62M USD
Net Income (TTM)21.99M USD
Revenue/Share0.30 RON
Last Price1.370 RON
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees374
CountryRO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINROBIOFACNOR9
Valuation
P/E (Trailing)19.57
P/E (Forward)—
PEG—
EV/EBITDA12.77
EV/Revenue3.88
P/S4.59
P/B3.42
EPS (TTM)0.07
EPS (Forward)—
52W Range
0.782082% of range1.495
52W High1.495 RON
52W Low0.7820 RON
Profitability
Gross Margin85.46%
Oper. Margin-23.94%
EBITDA Margin30.42%
Profit Margin31.51%
ROE18.35%
ROA15.80%
Growth
Revenue Growth-33.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF17.59M USD
CapEx (TTM)3.20M USD
FCF Margin52.16%
FCF Yield11.37%
Net Debt-45.20M USD
Net Debt/EBITDA-2.31
Balance Sheet
Debt/Equity0.00
Current Ratio1.90
Quick Ratio1.53
Book Value/Sh0.40 RON
Cash/Share0.21 RON
Dividends
Fwd Div Rate0.04 RON
Trail. Div Rate0.04 RON
Div. Yield3.07%
5Y Avg Yield3.52%
Payout Ratio105.19%
Ex-Div DateJun 29, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.985.37M
Float476.14M
Insiders92.74%
Institutions0.00%
Technical
SMA 501.357 (+1.0%)
SMA 2001.282 (+6.9%)
Beta0.50
S&P 52W Chg16.45%
Avg Vol (30d)3.48K
Avg Vol (10d)0
Technical Indicators
RSI (14)58.4
MACD0.0024
MACD Signal0.0031
MACD Hist.-0.0007
BB Upper1.370 RON
BB Middle1.370 RON
BB Lower1.370 RON
BB Width0.00%
ATR (14)0.0024 RON
Vol Ratio (20d)—